Information card for entry 2215975
Chemical name |
9-Methyl-2,6-di-<i>p</i>-tolyl-2,3,6,7-tetrahydro-1<i>H</i>,5<i>H</i>- pyrimido[5,6,1-<i>ij</i>]quinazoline |
Formula |
C25 H27 N3 |
Calculated formula |
C25 H27 N3 |
SMILES |
Cc1cc2CN(CN3c2c(c1)CN(C3)c1ccc(cc1)C)c1ccc(cc1)C |
Title of publication |
9-Methyl-2,6-di-<i>p</i>-tolyl-2,3,6,7-tetrahydro-1<i>H</i>,5<i>H</i>-pyrimido[5,6,1-<i>ij</i>]quinazoline |
Authors of publication |
Mahon, Andrew; Craig, Donald C.; Try, Andrew C. |
Journal of publication |
Acta Crystallographica Section E |
Year of publication |
2007 |
Journal volume |
63 |
Journal issue |
11 |
Pages of publication |
o4311 - o4311 |
a |
9.035 ± 0.003 Å |
b |
20.805 ± 0.007 Å |
c |
11.79 ± 0.003 Å |
α |
90° |
β |
110.95 ± 0.01° |
γ |
90° |
Cell volume |
2069.7 ± 1.1 Å3 |
Cell temperature |
294 K |
Number of distinct elements |
3 |
Hermann-Mauguin space group symbol |
P 1 21/c 1 |
Hall space group symbol |
-P 2ybc |
Residual factor for significantly intense reflections |
0.058 |
Weighted residual factors for all reflections included in the refinement |
0.065 |
Goodness-of-fit parameter for all reflections included in the refinement |
1.85 |
Diffraction radiation wavelength |
0.71073 Å |
Diffraction radiation type |
MoKα |
Has coordinates |
Yes |
Has disorder |
No |
Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2215975.html